Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Search
No matching results for ''
Tip: Try a valid symbol or a specific company name for relevant results
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
7,391.00
+87.70
(+1.20%)
ASX 200
7,145.60
+81.10
(+1.15%)
AUD/USD
0.7037
-0.0012
(-0.17%)
OIL
112.70
+0.49
(+0.44%)
GOLD
1,845.10
+3.90
(+0.21%)
BTC-AUD
41,657.98
-1,162.13
(-2.71%)
📩 Sign up now
News that makes you smarter and richer... For free.
Get Fully Briefed with Yahoo Finance, delivered straight to your inbox.
Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.5700
+0.1600
(+4.69%)
At close: 04:00PM EDT
3.5500
-0.02
(-0.56%)
After hours:
07:06PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
140,702
144,927
33,215
34,505
28,267
Operating expenses
Research development
152,237
141,891
90,570
80,141
95,955
Selling general and administrative
76,091
69,261
30,775
24,748
32,596
Total operating expenses
225,620
209,420
121,345
104,889
128,551
Operating income or loss
-84,918
-64,493
-88,130
-70,384
-100,284
Interest expense
3,126
2,910
2,924
502
-
Total other income/expenses net
-981
-1,045
981
-426
170
Income before tax
-86,737
-65,578
-89,127
-70,279
-98,942
Income from continuing operations
-86,737
-65,578
-89,127
-70,279
-98,942
Net income
-86,737
-65,578
-89,127
-70,279
-98,942
Net income available to common shareholders
-86,737
-65,578
-89,127
-70,279
-98,942
Basic EPS
-
-
-1.12
-1.24
-2.43
Diluted EPS
-
-
-1.12
-1.24
-2.43
Basic average shares
-
-
79,789
56,649
40,743
Diluted average shares
-
-
79,789
56,649
40,743
EBITDA
-
-56,721
-79,625
-62,174
-92,422
© 2022 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Privacy Dashboard
Privacy (updated)
About our ads
Terms (updated)